Prokidney PROK
NASDAQ PROK
$1.85 -0.14 (-7.04%)
At close: Sep 9, 2026 · 4:00 PM EDT

Prokidney (PROK) Income towards Parent Company (2021 - 2026)

Prokidney's (PROK) quarterly Income towards Parent Company came in at -$46.4 million in Q2 2026, down 25.62% year-over-year from -$62.4 million in Q2 2025, and down 8.95% quarter-over-quarter from -$42.6 million in Q1 2026.

Analysis

Prokidney (PROK) Income towards Parent Company (2021 - 2026) Analysis & Trends

Prokidney (PROK) has reported Income towards Parent Company for 6 consecutive years, with -$46.4 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Income towards Parent Company fell 25.62% year-over-year to -$46.4 million in Q2 2026; TTM through Jun 2026 was -$133.6 million, a 18.77% increase from a year earlier, with the FY2025 full-year figure at -$119.4 million, up 26.87% from the prior year.
  • Income towards Parent Company was -$46.4 million for Q2 2026 at Prokidney, down from -$42.6 million in the prior quarter.
  • Over five years, Income towards Parent Company peaked at -$8.7 million in Q4 2025 and troughed at -$67.5 million in Q1 2022.
  • A 5-year average of -$36.4 million and a median of -$36.9 million in 2023 frame the typical range for Income towards Parent Company.
  • Across the five-year window, Income towards Parent Company plunged 15476123.78% in 2022 and jumped 82.08% in 2025, its largest moves.
  • Over 5 years, Income towards Parent Company stood at -$24.6 million in 2022, then rose by 11.59% to -$21.7 million in 2023, then slumped by 123.18% to -$48.5 million in 2024, then jumped by 82.08% to -$8.7 million in 2025, then tumbled by 434.61% to -$46.4 million in 2026.
  • The last three Income towards Parent Company figures came in at -$46.4 million (Q2 2026), -$42.6 million (Q1 2026), and -$8.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn
10 Prokidney 346.07 Mn 346.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -46.44 Mn
Mar 31, 2026 -42.62 Mn
Dec 31, 2025 -8.69 Mn
Sep 30, 2025 -35.84 Mn
Jun 30, 2025 -36.97 Mn
Mar 31, 2025 -37.95 Mn
Dec 31, 2024 -48.48 Mn
Sep 30, 2024 -41.05 Mn
Jun 30, 2024 -38.47 Mn
Mar 31, 2024 -35.33 Mn
Dec 31, 2023 -21.72 Mn
Sep 30, 2023 -41.99 Mn
Jun 30, 2023 -34.82 Mn
Mar 31, 2023 -36.91 Mn
Dec 31, 2022 -24.57 Mn
Sep 30, 2022 -33.95 Mn
Jun 30, 2022 -22.13 Mn
Mar 31, 2022 -67.49 Mn
Dec 31, 2021 -13.82 Mn
Sep 30, 2021 -17.02 Mn